CHP Blogazine

CHP blogazine

2019
- Brett Skinner talks about pharmacare: CKLW AM800 Windsor »
  
  Posted on November 7, 2019
- Gaps in coverage for take-home cancer drugs in Canada »
  
  Posted on October 17, 2019
- Are the Real-World Data available in Canada suitable for drug reimbursement decisions? »
  
  Posted on September 24, 2019
- National pharmacare advisory council’s report leaves many unanswered questions. »
  
  Posted on July 24, 2019
- GLOBAL NEWS Radio's Danielle Smith interviews CHPI's Brett Skinner about pharmacare. »
  
  Posted on June 27, 2019
- Pharmacare Council dismissed less costly, less disruptive policy options and misdiagnosed the gap. »
  
  Posted on June 20, 2019
- Who will speak for the unmet needs of the sick? »
  
  Posted on March 25, 2019
- VIDEO - National Pharmacare Facts. »
  
  Posted on February 4, 2019
- NATIONAL POST RADIO's Emily Jackson interviews CHPI's Brett Skinner about pharmacare myths. »
  
  Posted on January 25, 2019
- Do Canadians really face a tradeoff between basic necessities and medicines? »
  
  Posted on January 19, 2019
2018
- GLOBAL NEWS AM640's Tasha Kheiriddin interviews CHPI's Brett Skinner about national pharmacare. »
  
  Posted on June 19, 2018
- CHPI leads evidence-based opposition to government-run monopoly pharmacare. »
  
  Posted on March 7, 2018
2017
- Federal government’s changes to drug price regulations will reduce access to new medicines. »
  
  Posted on December 1, 2017
- How do HTA decisions affect access to mental health drugs in Canada? »
  
  Posted on April 12, 2017
2016
- CHPI's Brett Skinner interviewed about pharmacare by Devon Peacock host of AM980 The Pulse. »
  
  Posted on December 8, 2016
- National pharmacare could be costly for patients and taxpayers. »
  
  Posted on March 2, 2016
2015
- Is Canada under-investing in medical technology? »
  
  Posted on July 12, 2015
- Are public drug budgets limited by false notions about the economic affordability of new medicines? »
  
  Posted on June 30, 2015
- Where are the best and worst public drug plans in Canada for patient access to new medicines? »
  
  Posted on June 30, 2015

Brett Skinner talks about pharmacare: CKLW AM800 Windsor »

Gaps in coverage for take-home cancer drugs in Canada »

Are the Real-World Data available in Canada suitable for drug reimbursement decisions? »

National pharmacare advisory council’s report leaves many unanswered questions. »

GLOBAL NEWS Radio's Danielle Smith interviews CHPI's Brett Skinner about pharmacare. »

Pharmacare Council dismissed less costly, less disruptive policy options and misdiagnosed the gap. »

Who will speak for the unmet needs of the sick? »

VIDEO - National Pharmacare Facts. »

NATIONAL POST RADIO's Emily Jackson interviews CHPI's Brett Skinner about pharmacare myths. »

Do Canadians really face a tradeoff between basic necessities and medicines? »

GLOBAL NEWS AM640's Tasha Kheiriddin interviews CHPI's Brett Skinner about national pharmacare. »

CHPI leads evidence-based opposition to government-run monopoly pharmacare. »

Federal government’s changes to drug price regulations will reduce access to new medicines. »

How do HTA decisions affect access to mental health drugs in Canada? »

CHPI's Brett Skinner interviewed about pharmacare by Devon Peacock host of AM980 The Pulse. »

National pharmacare could be costly for patients and taxpayers. »

Is Canada under-investing in medical technology? »

Are public drug budgets limited by false notions about the economic affordability of new medicines? »

Where are the best and worst public drug plans in Canada for patient access to new medicines? »

CHP blogazine

Gaps in coverage for take-home cancer drugs in Canada

Opinions

Pharmacare is unnecessary, bad for privately insured Canadians and costly for taxpayers.

Civil servants get the Rolls Royce of pharmacare while party leaders can't even muster a decent plan

New rules will keep the best medications from desperate Canadians

News

Health Canada requires hospitals to report adverse drug reactions and medical device incidents.

CADTH and BC Pharmacare move to ease entry of biosimilar drugs.

Council on the Implementation of National Pharmacare releases final report.

Log in

Log in

Register